World ADC San Diego 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
AbbVie at World ADC San Diego 2026
Oct 12–15, 2026 San Diego, CA ~1.3k attendees Website
AbbVie takes part in 5 sessions at World ADC San Diego 2026 in San Diego. Its sessions run from new payload biology to clinical results and manufacturing scale-up. Highlights include a first-in-class payload that blocks both PI3K and mTOR, and safety and efficacy data for ABBV-400 in colorectal cancer.
| Organization | World ADC San Diego 2026 Attendance |
|---|---|
AbbVie North Chicago, IL | |
Global pharmaceutical company developing antibody-drug conjugates in oncology, including ABBV-400 for colorectal and other solid tumors. | Talk Mon Oct 12 2:00pm Panel Mon Oct 12 2:30pm Talk Tue Oct 13 12:00pm Talk Wed Oct 14 9:00am Delving Into Discovery of Pan-PI3K & mTOR Dual Inhibitors as a First-in-Class ADC Payload ADC discovery chemistry |
Instantly find 20 buyers from AbbVie
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World ADC or its organizers. Submit a correction